Published in Eur J Immunol on September 01, 1999
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res (2005) 1.88
Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82
TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci U S A (2008) 1.72
Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci U S A (2004) 1.69
Neonatal Fc receptor and IgG-based therapeutics. MAbs (2011) 1.56
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging. Cancer Res (2005) 1.54
Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. J Biol Chem (2009) 1.44
Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol (2009) 1.42
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol (2013) 1.31
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Proc Natl Acad Sci U S A (2006) 1.26
Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol (2008) 1.20
Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res (2003) 1.16
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs (2010) 1.12
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun (2011) 1.11
Structural insights into neonatal Fc receptor-based recycling mechanisms. J Biol Chem (2014) 1.10
The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol (2012) 1.06
Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc Natl Acad Sci U S A (2009) 1.04
The Role of FcRn in Antigen Presentation. Front Immunol (2014) 0.93
Characterization and screening of IgG binding to the neonatal Fc receptor. MAbs (2014) 0.93
Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. J Biol Chem (2012) 0.90
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. J Clin Invest (2007) 0.90
Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK. Nucl Med Biol (2009) 0.87
Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding. J Biol Chem (2014) 0.87
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters. BioDrugs (2015) 0.87
Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins. Protein Eng Des Sel (2010) 0.86
Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions. Front Immunol (2015) 0.86
Engineering broadly neutralizing antibodies for HIV prevention and therapy. Adv Drug Deliv Rev (2016) 0.86
pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling. J Biol Chem (2014) 0.85
Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptor. MAbs (2014) 0.84
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody. MAbs (2014) 0.83
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life. MAbs (2015) 0.83
Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice. MAbs (2010) 0.82
Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies. J Biol Chem (2014) 0.81
A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life. MAbs (2015) 0.81
Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice. J Virol (2013) 0.81
Genetically delivered antibody protects against West Nile virus. Antiviral Res (2007) 0.81
Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn). J Biol Chem (2014) 0.80
A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Mol Imaging Biol (2014) 0.80
Targeting FcRn for the modulation of antibody dynamics. Mol Immunol (2015) 0.80
Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity. MAbs (2012) 0.79
Selection of nanobodies that target human neonatal Fc receptor. Sci Rep (2013) 0.78
On the perplexingly low rate of transport of IgG2 across the human placenta. PLoS One (2014) 0.77
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions. J Immunol (2015) 0.76
Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers. EJNMMI Res (2016) 0.75
Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice. PLoS One (2017) 0.75
Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development (2001) 5.46
The genes for fifteen ribosomal proteins of Saccharomyces cerevisiae. J Biol Chem (1981) 4.02
Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Annu Rev Immunol (2000) 3.19
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol (1996) 2.90
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol (2001) 2.87
Bacillus thuringiensis var. israelensis delta-endotoxin. Nucleotide sequence and characterization of the transcripts in Bacillus thuringiensis and Escherichia coli. J Mol Biol (1986) 2.62
Messenger RNA for ribosomal proteins in yeast. J Mol Biol (1983) 2.41
Sporulation of Clostridium perfringens in a modified medium and selected foods. Appl Microbiol (1967) 2.36
The nifA gene of Rhizobium meliloti is oxygen regulated. J Bacteriol (1987) 2.32
Mild temperature shock alters the transcription of a discrete class of Saccharomyces cerevisiae genes. Mol Cell Biol (1983) 2.19
Quantitative study of single molecule location estimation techniques. Opt Express (2009) 2.15
Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol (1998) 1.96
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol (2001) 1.93
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol (2009) 1.78
Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis (1987) 1.77
Cloning and expression in Escherichia coli of the insecticidal delta-endotoxin gene of Bacillus thuringiensis var. israelensis. FEBS Lett (1984) 1.77
Bacillus thuringiensis var. israelensis delta-endotoxin. Cloning and expression of the toxin in sporogenic and asporogenic strains of Bacillus subtilis. J Mol Biol (1986) 1.74
Survival of Clostridium perfringens During Baking and Holding of Turkey Stuffing. Appl Microbiol (1966) 1.73
C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol (2001) 1.71
Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis (1983) 1.62
Negative selection during the peripheral immune response to antigen. J Exp Med (2001) 1.59
Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur J Immunol (1994) 1.57
Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology (2000) 1.56
Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2001) 1.56
Schatzki's ring: long-term results following dilation. Gastrointest Endosc (1990) 1.51
The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J Mol Biol (1997) 1.51
Specific stimulation of simian virus 40 late transcription in vitro by a cellular factor binding the simian virus 40 21-base-pair repeat promoter element. Proc Natl Acad Sci U S A (1987) 1.50
An extended medial to lateral approach to mobilize the splenic flexure during laparoscopic low anterior resection. Colorectal Dis (2013) 1.47
Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol (2001) 1.47
Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone (2002) 1.47
Innate immunity as orchestrator of stem cell mobilization. Leukemia (2010) 1.46
Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol (1997) 1.45
The complete amino acid sequence of bovine heart cytochrome C1. Biochem Biophys Res Commun (1980) 1.43
Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. J Obstet Gynaecol (2009) 1.39
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol (1997) 1.39
HIV-infected cells are killed by rCD4-ricin A chain. Science (1988) 1.37
Cryptic reproductive isolation in the Drosophila simulans species complex. Evolution (2001) 1.36
Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res (2011) 1.32
A tetrodotoxin-producing Vibrio strain, LM-1, from the puffer fish Fugu vermicularis radiatus. Appl Environ Microbiol (2000) 1.31
A relation between inhibition of protein synthesis and conformation of 5'-phosphorylated 7-methylguanosine derivatives. J Mol Biol (1977) 1.31
Demonstration and assaying of IgG antibodies in tissues and on cells by labeled staphylococcal protein A. J Immunol Methods (1975) 1.30
Overlapping transcription of the nifA regulatory gene in Rhizobium meliloti. Gene (1986) 1.30
FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today (1997) 1.30
Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proc Natl Acad Sci U S A (1999) 1.29
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood (1993) 1.27
Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur J Immunol (1994) 1.26
NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics (1993) 1.25
Genetic structuring and transfer of marine dinoflagellate Cochlodinium polykrikoides in Japanese and Korean coastal waters revealed by microsatellites. Mol Ecol (2009) 1.24
Goat blood agar. Inexpensive media for culturing common bacterial pathogens. Trop Doct (1986) 1.23
The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol Immunol (1996) 1.23
Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev Biol (1997) 1.22
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol (1999) 1.22
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
Characterization of a bifunctional enzyme fusion of trehalose-6-phosphate synthetase and trehalose-6-phosphate phosphatase of Escherichia coli. Appl Environ Microbiol (2000) 1.20
RNA sequence and secondary structural determinants in a minimal viral promoter that directs replicase recognition and initiation of genomic plus-strand RNA synthesis. J Mol Biol (1999) 1.18
Spatial configuration of mRNA 5'-terminus. Nature (1977) 1.15
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood (1996) 1.15
Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J Neurochem (1998) 1.13
A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. Clin Cancer Res (2000) 1.13
Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins. Leukemia (2003) 1.12
CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol (1999) 1.11
Mechanisms of conspecific sperm precedence in Drosophila. Evolution (2000) 1.10
Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med (2000) 1.09
Development of the stress response inventory and its application in clinical practice. Psychosom Med (2001) 1.08
Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol (1999) 1.08
Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur J Immunol (1999) 1.08
Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci (1999) 1.08
Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract (2001) 1.08
Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1997) 1.07
Antimicrobial efficacy of endoscopic disinfection procedures: a controlled, multifactorial investigation. Gastrointest Endosc (1999) 1.07
Complementary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells. Mucosal Immunol (2010) 1.05
Immunogenomic approaches to study host immunity to enteric pathogens. Poult Sci (2007) 1.05
Purification, cDNA cloning and expression of an insect defensin from the great wax moth, Galleria mellonella. Insect Mol Biol (2004) 1.05
Identification of cell surface immunoglobulin markers by protein A-containing fluorescent staphylococci. Scand J Immunol (1974) 1.04
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Mol Pharmacol (1991) 1.04
A method for the detection and quantitation of Fc receptor sites on cells. Scand J Immunol (1976) 1.04
TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. Blood (1999) 1.04
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol (1989) 1.04
A novel homeobox gene, dharma, can induce the organizer in a non-cell-autonomous manner. Genes Dev (1998) 1.03
A human lymphoid cell line with an IgG-like membrane component. Eur J Immunol (1975) 1.03
Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. J Pharmacol Exp Ther (2000) 1.02
Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc (1990) 1.01
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation. Cytotherapy (2002) 1.01